Related by context. Frequent words. (Click for all words.) 63 ASA# 60 TroVax 59 vandetanib 58 ambrisentan 57 daclizumab 56 sunitinib 56 metastatic renal cell carcinoma 56 phase IIb 56 Torisel 55 blinatumomab 55 T DM1 54 bapineuzumab 54 pulmonary arterial hypertension PAH 54 asenapine 54 Exanta 54 elesclomol 53 epratuzumab 53 alfimeprase 52 cladribine 52 LymphoStat B 52 picoplatin 52 Bydureon 52 Vectibix 52 monotherapy 52 Dacogen 52 pirfenidone 52 talactoferrin 52 mipomersen 51 denufosol 51 RG# [001] 51 Afrezza 51 panitumumab 51 FTY# 51 Antegren 51 gefitinib 51 Trexima 51 Roche Holding AG ROG.VX 51 Avastin 50 Phase 2b study 50 liver metastases 50 VIDAZA 50 pimavanserin 50 TNFerade 50 Erbitux 50 Yondelis 50 Galvus 50 PF # [001] 50 Torcetrapib 50 Tykerb 50 mitoxantrone 49 erlotinib 49 HRPC 49 Tracleer 49 Cimzia 49 bortezomib 49 Telaprevir 49 telaprevir 49 Rhucin 49 pemetrexed 49 Phase IIa trial 49 dasatinib 49 Phase 2a trial 49 linaclotide 49 Actemra 49 Phase III trials 49 denosumab 48 AP# [003] 48 cetrorelix 48 Satraplatin 48 bone metastasis 48 indiplon 48 Phase IIb clinical 48 carfilzomib 48 adjuvant therapy 47 Santhera 47 liraglutide 47 satraplatin 47 tumor recurrence 47 golimumab 47 Qnexa 47 PEG INTRON 47 gemcitabine 47 Zerenex 47 disease progression 47 tumor shrinkage 47 INCB# [002] 47 Campath 47 chemoradiation 46 Xarelto 46 ipilimumab 46 sitagliptin 46 natalizumab 46 free survival PFS 46 rivaroxaban 46 Albuferon 46 voclosporin 46 Daxas 46 XGEVA 46 Onglyza 46 adjuvant chemotherapy 46 topotecan